title: 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.
abstract: Myeloid-derived suppressor cells (MDSC) accumulate in the spleen and tumor bed during tumor growth. They contribute to the immune tolerance of cancer notably by inhibiting the function of CD8(+) T cells. Thus, their elimination may hamper tumor growth by enhancing antitumor T-cell functions. We have previously reported that some anticancer agents relied on T cell-dependent anticancer responses to achieve maximal efficacy. However, the effect of anticancer agents on MDSC has remained largely unexplored. In this study, we observed that gemcitabine and 5-fluorouracil (5FU) were selectively cytotoxic on MDSC. In vivo, the treatment of tumor-bearing mice with 5FU led to a major decrease in the number of MDSC in the spleens and tumor beds of animals whereas no significant effect on T cells, natural killer cells, dendritic cells, or B cells was noted. Interestingly, 5FU showed a stronger efficacy over gemcitabine to deplete MDSC and selectively induced MDSC apoptotic cell death in vitro and in vivo. The elimination of MDSC by 5FU increased IFN-gamma production by tumor-specific CD8(+) T cells infiltrating the tumor and promoted T cell-dependent antitumor responses in vivo. Altogether, these findings suggest that the antitumor effect of 5FU is mediated, at least in part, by its selective cytotoxic action on MDSC.
authors.affiliation: INSERM Research Center 866, AVENIR Team, Faculty of Medicine, University of Burgundy, Anti-Cancer Center, Georges François Leclerc, Dijon, France.
authors.forename: Julie
authors.initials: J
authors.lastname: Vincent
authors.forename: Grégoire
authors.initials: G
authors.lastname: Mignot
authors.forename: Fanny
authors.initials: F
authors.lastname: Chalmin
authors.forename: Sylvain
authors.initials: S
authors.lastname: Ladoire
authors.forename: Mélanie
authors.initials: M
authors.lastname: Bruchard
authors.forename: Angélique
authors.initials: A
authors.lastname: Chevriaux
authors.forename: François
authors.initials: F
authors.lastname: Martin
authors.forename: Lionel
authors.initials: L
authors.lastname: Apetoh
authors.forename: Cédric
authors.initials: C
authors.lastname: Rébé
authors.forename: François
authors.initials: F
authors.lastname: Ghiringhelli
mesh_terms: D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D017209:Apoptosis; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology; D045744:Cell Line, Tumor; D003713:Dendritic Cells / Q000187:drug effects; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000494:pharmacology; D005434:Flow Cytometry; D005472:Fluorouracil / Q000494:pharmacology*; D007107:Immune System; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D005472:Fluorouracil; D000093542:Gemcitabine